Peetz Christopher bought ARQT
July 15, 2026 · Form 4 insider transaction
Peetz Christopher bought 21,486 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,486
Price
$0.00
Total value
N/A
InsiderPeetz Christopher
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 15, 2026
Filing dateJuly 17, 2026
Shares owned after21,486
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/3 each of the underlying shares subject to the option vest and become exercisable on the first annual anniversary of July 15, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the non-employee director's continued service through each applicable vesting date.